How to Choose the Right CDMO for Your Biologics Program Selecting a Contract Development and Manufacturing Organization (CDMO) is one of...
How to Choose the Right CDMO for Your Biologics Program
read more
Antibody-Drug Conjugates (ADC): From Concept to GMP Manufacturing
Antibody-Drug Conjugates (ADC): From Concept to GMP Manufacturing Antibody-drug conjugates (ADCs) represent a groundbreaking class of...
Interview – Challenges in the Development & Manufacturing of ADCs
Simone Seechi, R&D Process Chemist at Olon and Matthieu Culié, Head of Development & GMP Manufacturing at GTP Bioways were...
Choosing a Biologics CDMO: Your Blueprint for Success
In the dynamic and high-stakes world of biologics, selecting the right Contract Development and Manufacturing Organisation (CDMO) can make...
Mastering Complex Protein Purification: A Case Study on Achieving Optimal Downstream Processing
Case study: Effective removal of host cell proteins in high pI recombinant protein production The production of complex recombinant...
Overcoming Challenges in ADC Purification: A Case Study
Case study: Purification of an ADC to remove the residual free drug Among bioconjugates, antibody-drug conjugates (ADCs) represent a...
Why Choosing a Client-Centric CDMO for the Manufacturing of Your Biologics is Critical to the Success of Your Project?
In the rapidly evolving landscape of biopharmaceutical development, finding the right Contract Development and Manufacturing Organization...
Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19
Case study: Use of an innovative viral inactivation method for a complex recombinant protein to be used as vaccine for COVID-19 When...
